Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection

Microbiology and Immunology

Volumn 44, Issue 1, 2000, Pages 29-39

  Ikewaki, Junko ^a   Nishizono, Akira ^a   Goto, Takayuki ^a   Fujioka, Toshio ^a   Mifune, Kumato ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Secretory IgA; Th2 cells; Therapeutic vaccination

Indexed keywords

BACTERIAL VACCINE; CHOLERA TOXIN; IMMUNOGLOBULIN A; INTERLEUKIN 4; MESSENGER RNA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTRITIS; GENE EXPRESSION; HELICOBACTER PYLORI; HELPER CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PERSISTENT INFECTION; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 0033979331     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2000.tb01243.x     Document Type: Article

References (28)

1. Bardhan, P.K. 1997. Epidemiological features of Helicobacter pylori infection in developing countries. Clin. Infect. Dis. 25: 973-978.
2. Corthésy-Theulaz, I., Porta, N., Glauser, M., Saraga, E., Vanney, A.C., Hass, R., Kraehenbuhl, J.P., Blum, A.L., and Michetti, P. 1995. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 109: 115-121.
3. Cuenca, R., Blanchard, T.G., Czinn, S.J., Nedrud, J.G., Monath, T.P., Lee, C.K., and Redline, R.W. 1996. Therapeutic immunization against Helicobacter musterae in naturally infected ferrets. Gastroenterology 110: 1770 1775.
4. Czinn, S.J., and Nedrud, J.G. 1991. Oral immunization against Helicobacter pylori. Infect. Immun. 59: 2359-2363.
5. Czinn, S.J., Cai, A., and Nedrud, J.G. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral passive IgA immunization. Vaccine 11: 637-642.
6. Doidge, C., Gust, I., Lee, A., Buck, F., Hazell, S., and Manne, U. 1994. Therapeutic immunization against Helicobacter infection. Lancet 343: 914-915.
7. Elson, C.O., and Ealding, W. 1984. Generalized systemic and mucosal immunity on mice after mucosal stimulation with cholera toxin. J. Immunol. 132: 2736-2741.
8. Eurogast Study Group. 1993. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341: 1359-1362.
9. Ghiara, P., Rossi, M., Marchetti, M., DiTummaso, A., Vindigni, C., Ciampolini, F., Covacci, A., Telford, J.L., Magistris, M.T., Pozza, M., Rappuoli, R., and Giudice, G.D. 1997. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect. Immun. 65: 4996-5002.
10. Goto, T., Nishizono, A., Fujioka, T., Ikewaki, J., Mifune, K., and Nasu, M. 1999. Local secretory IgA and post-immunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect. Immun. 67: 2531-2539.
11. Guy, B., Hessler, C., Fourage, S., Rokbi, B., Quentin Millet, M.-J. 1999. Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice. Vaccine 17: 1130-1135.
12. Honda, S., Fujioka, T., Tokieda, M., Satoh, R., Nishizono, A., and Nasu, M. 1998. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 58: 4255-4259.
13. Lee, A., O'Rourke, J., DeUngria, M.C., Robertson, B., Daskalopoulos, G., and Dixon, M.F. 1997. A standardized mouse model of Helicobacter pylori infection: inducing the Sydney strain. Gastroenterology 112: 1386-1397.
14. Lee, C.K., Weltzin, R., Thomas, W.D., Jr., Kleanthous, H., Ermak, T.H., Soman, G., Hill, J.E., Ackerman, S.K., and Monath, T.P. 1995. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172: 161-172.
15. Marinaro, M., Staats, H.F., Hiroi, T., Jackson, R.J., Coste, M., Boyaka, P.N., Okahashi, N., Yamamoto, M., Kiyono, H., Bluethmann, H., Fujihashi, K., and McGhee, J.R. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of helper 2 cells and IL-4. J. Immunol. 155: 4621-4629.
16. Mattsson, A., Lönroth, H., Quiding-Järbrink, M., and Svennerholm, A.M. 1998. Induction of B-cell responses in the stomach of Helicobacter pylori infected subjects after oral cholera vaccination. J. Clin. Invest. 102: 51-56.
17. Mestecky, J. 1989. The common mucosal system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7: 265-276.
18. Michelti, P., Corthésy-Theulaz., I., Davin, C., Haas, R., Vaney, A.C., Heintz, M., Bille, J., Kraehenbuhl, J.P., Saraga, E., and Blum, A.L. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gustroenterology 107: 1002-1011.
19. Mohammadi, M., Czinn, S., Redline, R., and Nedrud, J. 1996. Helicobacter-specitic cell-mediated immune response display a predominant Th1 phenotype and promote a delayed-lype hypersensitivity response in the stomachs of mice. J. Immunol. 156: 4729-4738.
20. National Institutes of Health Consensus Conference. 1994. Helicobacter pylori in peptic ulcer disease. JAMA 272: 65-69.
21. Pappo, J., and Ermak, T.H. 1989. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium : a quantitative model for M cell uptake. Clin. Exp. Immunol. 76: 144-148.
22. Pappo, J., Thomas, W.D., Jr., Kabok, Z., Taylor, N.S., Murphy, J.C., and Fox, J.G. 1995. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect. Immun. 63: 1246-1252.
23. Saldinger, P.P., Porta, N., Launois, P., Louis, J.A., Waanders, O.A., Bouzourène, H., Michetti, P., Blum, A.L., and Corthésy-Theulaz, I.E. 1998. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 115: 891-897.
24. Spangler, B.D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56: 622.
25. Taylor, D.N., and Parsonnet, J. 1994. Epidemiology and natural history of Helicobacter pylori infection. In Blaser, M.J., Smith, P.D., and Ravgin, J. (eds). Infections of the gastrointestinal tract. Raven Press, New York.
26. Unge, P. 1997. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 133: S131-S148.
27. Wyatt, J.I., and Rathbone, B.J. 1988. Immune response of the gastric mucosa to Campylobacter pylori. Scand. J. Gastroenterol. 142 (Suppl): 44-49.
28. Xu-Amano, J., Kiyono, H., Jackson, R.J., Staats, H.F., Fujihashi, K., Burrows, P.D., Elson, C.O., Pillai, S., and McGhee, J.R. 1993. Helper T cell subsets for immunoglobulin A response: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178: 1309-1320.